194 related articles for article (PubMed ID: 31229551)
41. Postnatal Deletion of Bmal1 in Cardiomyocyte Promotes Pressure Overload Induced Cardiac Remodeling in Mice.
Liang Q; Xu H; Liu M; Qian L; Yan J; Yang G; Chen L
J Am Heart Assoc; 2022 Jul; 11(13):e025021. PubMed ID: 35730615
[TBL] [Abstract][Full Text] [Related]
42. Aldehyde dehydrogenase 2 deficiency blunts compensatory cardiac hypertrophy through modulating Akt phosphorylation early after transverse aorta constriction in mice.
Xia G; Fan F; Liu M; Wang S; Wu J; Shen C; Han S; Wang C; Jia J; Zou Y; Hu K; Ge J; Sun A
Biochim Biophys Acta; 2016 Sep; 1862(9):1587-93. PubMed ID: 27239698
[TBL] [Abstract][Full Text] [Related]
43. Hyperoside Protects Against Pressure Overload-Induced Cardiac Remodeling via the AKT Signaling Pathway.
Wang X; Liu Y; Xiao L; Li L; Zhao X; Yang L; Chen N; Gao L; Zhang J
Cell Physiol Biochem; 2018; 51(2):827-841. PubMed ID: 30466089
[TBL] [Abstract][Full Text] [Related]
44. Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis.
Wu MP; Zhang YS; Xu X; Zhou Q; Li JD; Yan C
Cardiovasc Drugs Ther; 2017 Apr; 31(2):157-166. PubMed ID: 28321644
[TBL] [Abstract][Full Text] [Related]
45. Urotensin II induction of adult cardiomyocytes hypertrophy involves the Akt/GSK-3beta signaling pathway.
Gruson D; Ginion A; Decroly N; Lause P; Vanoverschelde JL; Ketelslegers JM; Bertrand L; Thissen JP
Peptides; 2010 Jul; 31(7):1326-33. PubMed ID: 20416349
[TBL] [Abstract][Full Text] [Related]
46. Protective Roles of Interferon-γ in Cardiac Hypertrophy Induced by Sustained Pressure Overload.
Kimura A; Ishida Y; Furuta M; Nosaka M; Kuninaka Y; Taruya A; Mukaida N; Kondo T
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29555642
[TBL] [Abstract][Full Text] [Related]
47. Maresin-1 induces cardiomyocyte hypertrophy through IGF-1 paracrine pathway.
Wahyuni T; Kobayashi A; Tanaka S; Miyake Y; Yamamoto A; Bahtiar A; Mori S; Kametani Y; Tomimatsu M; Matsumoto K; Maeda M; Obana M; Fujio Y
Am J Physiol Cell Physiol; 2021 Jul; 321(1):C82-C93. PubMed ID: 34038245
[TBL] [Abstract][Full Text] [Related]
48. Celecoxib, but not rofecoxib or naproxen, attenuates cardiac hypertrophy and fibrosis induced in vitro by angiotensin and aldosterone.
Wang BH; Bertucci MC; Ma JY; Adrahtas A; Cheung RY; Krum H
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):912-8. PubMed ID: 20497423
[TBL] [Abstract][Full Text] [Related]
49. Apoptosis of cardiomyocytes in diabetic cardiomyopathy involves overexpression of glycogen synthase kinase-3β.
Wu W; Liu X; Han L
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30237226
[TBL] [Abstract][Full Text] [Related]
50. Qiliqiangxin inhibits the development of cardiac hypertrophy, remodeling, and dysfunction during 4 weeks of pressure overload in mice.
Zou Y; Lin L; Ye Y; Wei J; Zhou N; Liang Y; Gong H; Li L; Wu J; Li Y; Jia Z; Wu Y; Zhou J; Ge J
J Cardiovasc Pharmacol; 2012 Mar; 59(3):268-80. PubMed ID: 22075750
[TBL] [Abstract][Full Text] [Related]
51. PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway.
Palfi A; Toth A; Hanto K; Deres P; Szabados E; Szereday Z; Kulcsar G; Kalai T; Hideg K; Gallyas F; Sumegi B; Toth K; Halmosi R
J Mol Cell Cardiol; 2006 Jul; 41(1):149-59. PubMed ID: 16716347
[TBL] [Abstract][Full Text] [Related]
52. Celecoxib, a cyclooxygenase-2 inhibitor, reduces neointimal hyperplasia through inhibition of Akt signaling.
Yang HM; Kim HS; Park KW; You HJ; Jeon SI; Youn SW; Kim SH; Oh BH; Lee MM; Park YB; Walsh K
Circulation; 2004 Jul; 110(3):301-8. PubMed ID: 15238462
[TBL] [Abstract][Full Text] [Related]
53. A critical role of cardiac fibroblast-derived exosomes in activating renin angiotensin system in cardiomyocytes.
Lyu L; Wang H; Li B; Qin Q; Qi L; Nagarkatti M; Nagarkatti P; Janicki JS; Wang XL; Cui T
J Mol Cell Cardiol; 2015 Dec; 89(Pt B):268-79. PubMed ID: 26497614
[TBL] [Abstract][Full Text] [Related]
54. Sodium (±)-5-bromo-2-(α-hydroxypentyl) benzoate ameliorates pressure overload-induced cardiac hypertrophy and dysfunction through inhibiting autophagy.
Wang B; Shen D; Tang J; Li J; Xiao Y; Chen X; Cao C; Han D; Gao E; Zhao W; Zhang J; Chang J
J Cell Mol Med; 2019 Sep; 23(9):6048-6059. PubMed ID: 31222939
[TBL] [Abstract][Full Text] [Related]
55. Tripartite motif‑containing 14 may aggravate cardiac hypertrophy via the AKT signalling pathway in neonatal rat cardiomyocytes and transgenic mice.
Hou H; Chen Y; Feng X; Xu G; Yan M
Mol Med Rep; 2023 Sep; 28(3):. PubMed ID: 37503784
[TBL] [Abstract][Full Text] [Related]
56. Glycogen synthase kinase-3beta regulates post-myocardial infarction remodeling and stress-induced cardiomyocyte proliferation in vivo.
Woulfe KC; Gao E; Lal H; Harris D; Fan Q; Vagnozzi R; DeCaul M; Shang X; Patel S; Woodgett JR; Force T; Zhou J
Circ Res; 2010 May; 106(10):1635-45. PubMed ID: 20360256
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of heat shock protein 70 blocks the development of cardiac hypertrophy by modulating the phosphorylation of histone deacetylase 2.
Yoon S; Kim M; Min HK; Lee YU; Kwon DH; Lee M; Lee S; Kook T; Joung H; Nam KI; Ahn Y; Kim YK; Kim J; Park WJ; McMullen JR; Eom GH; Kook H
Cardiovasc Res; 2019 Nov; 115(13):1850-1860. PubMed ID: 30596969
[TBL] [Abstract][Full Text] [Related]
58. Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling.
Ai W; Zhang Y; Tang QZ; Yan L; Bian ZY; Liu C; Huang H; Bai X; Yin L; Li H
J Cell Biochem; 2010 Aug; 110(5):1111-22. PubMed ID: 20564207
[TBL] [Abstract][Full Text] [Related]
59. Adapter molecule DOC-2 is differentially expressed in pressure and volume overload hypertrophy and inhibits collagen synthesis in cardiac fibroblasts.
Kumbar DH; VanBergen A; Ocampo C; Muangmingsuk S; Griffin AJ; Gupta M
J Appl Physiol (1985); 2007 May; 102(5):2024-32. PubMed ID: 17255372
[TBL] [Abstract][Full Text] [Related]
60. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M
Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]